NO169875C - Fremgangsmaate for fremstilling av et konsentrat av den anti-hemofile faktor viii - Google Patents

Fremgangsmaate for fremstilling av et konsentrat av den anti-hemofile faktor viii

Info

Publication number
NO169875C
NO169875C NO84844610A NO844610A NO169875C NO 169875 C NO169875 C NO 169875C NO 84844610 A NO84844610 A NO 84844610A NO 844610 A NO844610 A NO 844610A NO 169875 C NO169875 C NO 169875C
Authority
NO
Norway
Prior art keywords
hemofile
concentrate
preparing
procedure
factor viii
Prior art date
Application number
NO84844610A
Other languages
English (en)
Norwegian (no)
Other versions
NO844610L (no
NO169875B (no
Inventor
Mirella Ezban Rasmussen
Ole Nordfang
Original Assignee
Nordisk Insulinlab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27220842&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO169875(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from DK127483A external-priority patent/DK127483D0/da
Priority claimed from DK549483A external-priority patent/DK157170C/da
Application filed by Nordisk Insulinlab filed Critical Nordisk Insulinlab
Publication of NO844610L publication Critical patent/NO844610L/no
Publication of NO169875B publication Critical patent/NO169875B/no
Publication of NO169875C publication Critical patent/NO169875C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0011—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods
    • A61L2/0023—Heat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/02—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using physical phenomena
    • A61L2/04—Heat
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood
    • Y10S530/83—Plasma; serum

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NO84844610A 1983-05-09 1984-11-20 Fremgangsmaate for fremstilling av et konsentrat av den anti-hemofile faktor viii NO169875C (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DK127483A DK127483D0 (da) 1983-05-09 1983-05-09 Fremgangsmade til fremstilling af et koncentrat af den anti-hemofile faktor viii
DK549483A DK157170C (da) 1983-05-09 1983-12-01 Koncentrat af den anti-hæmofile Faktor VIII samt fremgangsmåde til fremstilling deraf
DK64684A DK64684A (da) 1983-05-09 1984-02-14 Fremgangsmaade til fremstilling af et koncentrat af den anti-haemofile faktor viii
PCT/DK1984/000019 WO1984003628A1 (en) 1983-05-09 1984-03-20 A concentrate of the antihemophilic factor viii and a process for producing it

Publications (3)

Publication Number Publication Date
NO844610L NO844610L (no) 1984-11-20
NO169875B NO169875B (no) 1992-05-11
NO169875C true NO169875C (no) 1992-08-19

Family

ID=27220842

Family Applications (1)

Application Number Title Priority Date Filing Date
NO84844610A NO169875C (no) 1983-05-09 1984-11-20 Fremgangsmaate for fremstilling av et konsentrat av den anti-hemofile faktor viii

Country Status (6)

Country Link
US (1) US4650858A (fi)
EP (1) EP0148843B2 (fi)
DE (1) DE3481109D1 (fi)
FI (1) FI80382C (fi)
NO (1) NO169875C (fi)
WO (1) WO1984003628A1 (fi)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK525384D0 (da) * 1984-11-05 1984-11-05 Nordisk Insulinlab Praeparat paa basis af faktor viii til behandling af haemofili a inhibitorpatienter samt fremgangsmaade til fremstilling af et saadan praeparat
SE8501050D0 (sv) * 1985-03-05 1985-03-05 Kabivitrum Ab Biologically active fragments of human antihemophilic factor and method for preparation thereof
GB8505882D0 (en) * 1985-03-07 1985-04-11 Central Blood Lab Authority Purification of blood coagulation factor viii
DE3625090A1 (de) * 1986-07-24 1988-01-28 Behringwerke Ag Mittel zur therapie faktor viii-resistenter haemophilie a und verfahren zu seiner herstellung
EP0321835B1 (en) * 1987-12-21 1994-09-28 Miles Inc. Gel filteration of factor VIII
DE69002033T2 (de) * 1989-05-24 1993-09-30 Miles Inc Gelfiltration von wärmebehandeltem Faktor VIII.
DE4111393A1 (de) * 1991-04-09 1992-10-15 Behringwerke Ag Stabilisierte faktor viii-praeparationen
DE69333928T2 (de) * 1992-04-30 2006-08-17 Probitas Pharma Inc., Los Angeles Verbesserte solubilisierung und stabilisierung des faktor viii-komplexes
US5330974A (en) * 1993-03-01 1994-07-19 Fibratek, Inc. Therapeutic fibrinogen compositions
GB9424732D0 (en) * 1994-12-08 1995-02-08 Common Services Agency Heat treated blood plasma proteins
US5659017A (en) * 1995-11-07 1997-08-19 Alpha Therapeutic Corporation Anion exchange process for the purification of Factor VIII
DK2130554T3 (da) 1999-02-22 2012-12-03 Univ Connecticut Albuminfrie faktor VIII-præparater
CN102139114A (zh) * 2003-02-26 2011-08-03 尼克塔治疗公司 聚合物-因子viii部分缀合物
AU2009313325B2 (en) * 2008-11-07 2014-05-01 Takeda Pharmaceutical Company Limited Factor VIII formulations
RU2589254C2 (ru) 2009-06-09 2016-07-10 ПРОЛОНГ ФАРМАСЬЮТИКАЛЗ, ЭлЭлСи Композиции гемоглобина
WO2013039449A1 (en) 2011-09-16 2013-03-21 Ge Healthcare Bio-Sciences Ab Plasma protein fractionation by sequential polyacid precipitation

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3652530A (en) * 1967-08-28 1972-03-28 American Nat Red Cross Antihemophilic factor prepared from blood plasma using polyethylene glycol
US3631018A (en) * 1970-05-01 1971-12-28 Baxter Laboratories Inc Production of stable high-potency human ahf using polyethylene glycol and glycine to fractionate a cryoprecipitate of ahf concentrate
US3682881A (en) * 1970-10-02 1972-08-08 Baxter Laboratories Inc Fractionation of plasma using glycine and polyethylene glycol
US4069216A (en) * 1975-06-16 1978-01-17 Edward Shanbrom, Inc. Simplified methods for preparation of very high purity Factor VIII concentrate
US4027013A (en) * 1976-01-22 1977-05-31 William L. Wilson Clottable fibrinogen free factor VIII and albumin product and process
JPS52125609A (en) * 1976-04-09 1977-10-21 Green Cross Corp:The Purification of agglutination factor viii
DE2916711A1 (de) * 1979-04-25 1980-11-06 Behringwerke Ag Blutgerinnungsfaktoren und verfahren zu ihrer herstellung
FR2460305A2 (fr) * 1979-06-29 1981-01-23 Merieux Inst Procede de preparation d'un concentre de facteur viii
SE448945B (sv) * 1979-12-20 1987-03-30 Blombaeck E G B Forfarande for rening och /eller koncentrering av faktor viii-komplexet
US4289691A (en) * 1980-01-18 1981-09-15 The Canadian Red Cross Society Method of obtaining intermediate purity factor VIII
US4386068A (en) * 1980-02-26 1983-05-31 Cutter Laboratories, Inc. Antihemophilic factor concentrate and method for preparation
AT369263B (de) * 1980-08-27 1982-12-27 Immuno Ag Verfahren zur herstellung eines faktor viii(ahf) -hochkonzentrates
ATE39324T1 (de) * 1981-04-08 1989-01-15 Atomic Energy Authority Uk Blutfraktionierung.
US4435318A (en) * 1981-05-22 1984-03-06 Ionics, Incorporated Electrodialysis preparation of purified AHF concentrate
JPS5874617A (ja) * 1981-10-28 1983-05-06 Green Cross Corp:The 人由来血液凝固第７因子含有水溶液の加熱処理方法
US4361509A (en) 1981-12-14 1982-11-30 Scripps Clinic And Research Foundation Ultrapurification of factor VIII using monoclonal antibodies
US4495175A (en) * 1982-08-05 1985-01-22 University Of Rochester Preparation of highly purified human antihemophilic factor
US4478825A (en) * 1983-10-14 1984-10-23 Armour Pharmaceutical Company Warm ethanol method for preparation of low fibrinogen antihemophilic factor
US4508709A (en) * 1983-12-05 1985-04-02 Armour Pharmaceutical Company Process for purifying factor VIII:C
US4486410A (en) * 1984-02-09 1984-12-04 Armour Pharmaceutical Company Heat defibrinogenation of AHF preparation
US4543210A (en) * 1984-10-04 1985-09-24 Miles Laboratories, Inc. Process for producing a high purity antihemophilic factor concentrate

Also Published As

Publication number Publication date
DE3481109D1 (de) 1990-03-01
NO844610L (no) 1984-11-20
WO1984003628A1 (en) 1984-09-27
US4650858A (en) 1987-03-17
FI80382C (fi) 1990-06-11
FI844557A0 (fi) 1984-11-20
FI844557L (fi) 1984-11-20
EP0148843A1 (en) 1985-07-24
EP0148843B1 (en) 1990-01-24
FI80382B (fi) 1990-02-28
EP0148843B2 (en) 1994-05-04
NO169875B (no) 1992-05-11

Similar Documents

Publication Publication Date Title
NO843956L (no) Fremgangsmaate for fremstilling av karboksyalkenamido-cefalosporiner
RO90861A (ro) Procedeu pentru prepararea etielnglicolului
NO850597L (no) Fremgangsmaate for fremstilling av emulsjoner
NO843592L (no) Fremgangsmaate for fremstilling av et polypeptid
NO169875C (no) Fremgangsmaate for fremstilling av et konsentrat av den anti-hemofile faktor viii
NO157884C (no) Fremgangsmaate for fremstilling av et faktor viii(ahf)-hoeykonsentrat.
NO844631L (no) Fremgangsmaate for fremstilling av tremasse
NO170019C (no) Fremgangsmaate for fremstilling av deglucoteicoplanin (antibiotikum l 17392)
NO845207L (no) Fremgangsmaate for fremstilling av diaminopolyalkenyletere
ES536780A0 (es) Procedimiento de preparar nuevas bencensulfonil-lactamas
ES526734A0 (es) Procedimiento de preparar derivados de sulfato de hidroxilamonio
DK463484D0 (da) Dyrkningsbeholder
NO841965L (no) Fremgangsmaate for fremstilling av 1,8-dihydroksy-10-acyl-9-antron-derivater
NO844090L (no) Fremgangsmaate for fremstilling av 2-azacykloalkyltio-2-penem-3-karboksylsyre-derivater
NO169575C (no) Fremgangsmaate for fremstilling av en galenisk form av sulpirid
DK127483D0 (da) Fremgangsmade til fremstilling af et koncentrat af den anti-hemofile faktor viii
DK64684A (da) Fremgangsmaade til fremstilling af et koncentrat af den anti-haemofile faktor viii
DE3460280D1 (en) Process for the preparation of n-methylhomoveratryl amine
DE3462139D1 (en) Process for the preparation of hydroxybenzylphosphonium salts
DE3369325D1 (en) Process for the preparation of bisphosphine dioxides
ES538563A0 (es) Un procedimiento de preparar un derivado de 1-aril-1h-tetrazol
NO844466L (no) Fremgangsmaate for fremstilling av pyrimidoisokinolin-derivater
NO841485L (no) Fremgangsmaate for fremstilling av substituerte difenylazometinderivater
PT79295B (en) Process for the preparation of azolyltetrahydrofuran-2-ylidene-methane derivatives having a fungicidal effect
GB2140417B (en) A process for the preparation of n-aryloxybenzoyl sulphonamides